Holman, Rury R; Haffner, Steven M; McMurray, John J; Bethel, M Angelyn; Holzhauer, Björn; Hua, Tsushung A; Belenkov, Yuri; Boolell, Mitradev; Buse, John B; Buckley, Brendan M; Chacra, Antonio R; Chiang, Fu-Tien; Charbonnel, Bernard; Chow, Chun-Chung; Davies, Melanie J; Deedwania, Prakash; Diem, Peter; Einhorn, Daniel; Fonseca, Vivian; Fulcher, Gregory R; ... (2010). Effect of nateglinide on the incidence of diabetes and cardiovascular events. New England journal of medicine NEJM, 362(16), pp. 1463-76. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa1001122
Full text not available from this repository. (Request a copy)The ability of short-acting insulin secretagogues to reduce the risk of diabetes or cardiovascular events in people with impaired glucose tolerance is unknown.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition |
UniBE Contributor: |
Diem, Peter |
ISSN: |
0028-4793 |
Publisher: |
Massachusetts Medical Society MMS |
Language: |
English |
Submitter: |
Peter Alfred von Ballmoos-Haas |
Date Deposited: |
04 Oct 2013 14:08 |
Last Modified: |
05 Dec 2022 14:00 |
Publisher DOI: |
10.1056/NEJMoa1001122 |
PubMed ID: |
20228402 |
Web of Science ID: |
000276894700006 |
URI: |
https://boris.unibe.ch/id/eprint/359 (FactScience: 197704) |
Actions (login required)
 |
Edit item |